跳至主要内容
临床试验/JPRN-UMIN000010785
JPRN-UMIN000010785招募中未知

Efficacy of neoadjuvant Gemcitabin-Cisplatin chemotherapy for upper urinary tract carcinoma - Randomized comtrolled traial - Efficacy of neoadjuvant Gemcitabin-Cisplatin chemotherapy for upper urinary tract carcinoma - Randomized comtrolled traial

osaka medical college department of urology0 个研究点目标入组 100 人开始时间: 2013年5月23日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Serious active infection 2)Temperature(<38) 3)Serious intercurrent medical or psychiatric illness 4)Prior malignancy [the patient has been disease free under 5 years] 5)peripheral neuropathy 6)Drug allergy or Pre-existing 7)If female of childbearing potential, pregnancy test is possitive 8)Others; based on the physicians' judgement

研究者

发起方
osaka medical college department of urology

相似试验

进行中(未招募)
1 期
Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.Cholangiocarcinoma and gallbladder carcinomaMedDRA version: 20.0Level: LLTClassification code 10017620Term: Gallbladder carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-005078-70-ATniversity Medical Center Hamburg-Eppendorf440
进行中(未招募)
1 期
Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.Cholangiocarcinoma and gallbladder carcinomaMedDRA version: 20.0Level: LLTClassification code 10017620Term: Gallbladder carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-005078-70-ITIVERSITäTKLINIKUM HAMBURG-EPPENDORF781
进行中(未招募)
1 期
Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.Cholangiocarcinoma and gallbladder carcinomaMedDRA version: 20.0 Level: LLT Classification code 10017620 Term: Gallbladder carcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10008593 Term: Cholangiocarcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-005078-70-DKniversity Medical Center Hamburg-Eppendorf60
招募中
3 期
Adjuvant chemotherapy with gemcitabine and cisplatin compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial)Biliary tract cancerCholangio/gallblader carcinoma10019815
NL-OMON53034Amsterdam UMC172
进行中(未招募)
1 期
Prophylactic combined chemotherapy for patients with cholangiocarcinoma after curative intent of carcinoma resection and muscle invasive gallbladder carcinoma.Cholangiocarcinoma and gallbladder carcinomaMedDRA version: 20.0Level: LLTClassification code 10017620Term: Gallbladder carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2012-005078-70-DEniversity Medical Center Hamburg-Eppendorf781